![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, January 16, 2024 6:08:23 PM
“and have been instrumental in establishing more than 40 collaborations and co-operative agreements with major pharmaceutical and biotech companies, “
“I have over 30 years’ experience in the multinational pharmaceutical and biotechnology industries spanning senior roles in Research and Development, Marketing, Sales and Strategic Planning, including managerial positions with Sanofi-Aventis, GlaxoSmithKline, DuPont-Merck Pharmaceuticals, Gemini Genomics Inc. and Locus Pharmaceuticals Inc. Key positions held include: Head of Marketing and Sales, Vice President, Marketing and Business Development, and Chief Business Officer. I was also previously CEO of Nuevolution A/S based in Copenhagen, Denmark (acquired by Amgen) and CEO of Marillion Pharmaceuticals Inc. Presently I serve as Executive Chairman of Eppin Pharma Inc and CEO of Aestas Pharma Inc, both emerging biopharmaceutical companies. I have also raised over $50MM from venture capital firms to fund biotechnology enterprises, and have been instrumental in establishing more than 40 collaborations and co-operative agreements with major pharmaceutical and biotech companies, including licensing, co-marketing and acquisition transactions valued in excess of $600MM. Other career highlights include the successful launches of "blockbuster" drugs, including Imitrex®, Celexa®, Prinivil®/Zestril®, Sinemet CR® and Viazem®/Tiazac®, and the successful $100 MM IPO of Gemini Genomics Inc. and it's subsequent $220MM sale to Sequenom Inc.“
Recent ATRX News
- Form SEC STAFF ACTION - SEC Staff Action: ORDER • Edgar (US Regulatory) • 01/30/2024 09:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:25:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 09:01:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:01:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:51:55 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 09:35:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 08:58:43 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM